Search results
Results from the WOW.Com Content Network
PLOS Pathogens is a peer-reviewed open-access medical journal. All content in PLOS Pathogens is published under the Creative Commons "by-attribution" license. PLOS Pathogens began operation in September 2005. It was the fifth journal of the Public Library of Science (PLOS), a non-profit open-access publisher.
Heitman's research has largely focused on studies of model and pathogenic fungi to address unsolved problems in biology and medicine. Pioneering research with the model budding yeast Saccharomyces cerevisiae discovered TOR and FKBP12 as the targets of the immunosuppressive and antiproliferative drug rapamycin, now widely used in organ transplantation and cancer chemotherapy.
PLOS (for Public Library of Science; PLoS until 2012 [1]) is a nonprofit publisher of open-access journals in science, technology, and medicine and other scientific literature, under an open-content license.
Karen Louise Mossman is a Canadian virologist who is a professor of Pathology and Molecular Medicine at McMaster University.Mossman looks to understand how viruses get around the defence mechanisms of cells.
The idea is that, instead, PLOS One only verifies whether experiments and data analysis were conducted rigorously, and leaves it to the scientific community to ascertain importance, post publication, through debate and comment. [26] Each submission will be assessed by a member of the PLOS ONE Editorial Board before publication. This pre ...
She is currently head of the Molecular Virology Laboratory at the Leloir Institute Foundation, [18] [14] [19] [20] independent researcher at the National Council for Scientific and Technical Research (CONICET), [18] [14] associate editor of the journal PLoS Pathogens, and member of the editorial board of the journal Virology. [21] [22] [23] [24]
Dr. Cullen has served as an Associate Editor for Cell, and PLoS Pathogens. [26] He has also served as an editorial board member for several major journals. External links
Gordon Dougan is a professor in the Department of Medicine at the University of Cambridge and head of pathogen research and a member of the board of management at the Wellcome Sanger Institute in Cambridge, United Kingdom. [4] He is also a Fellow of Wolfson College, Cambridge. During his career, Dougan has pioneered work on enteric diseases and ...